Health

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo, to treat Acute Respiratory Distress Syndrome (ARDS) due to Covid-19. Direct Biologics is the first and only EV […]

thaipr.net

27 เม.ย. 65

Octapharma to address unmet needs in von Willebrand disease as a proud sponsor of WFH 2022 World Congress

As part of its ongoing commitment to the global bleeding disorders community, Octapharma is pleased to be a Gold Sponsor of the upcoming World Federation of Haemophilia (WFH) 2022 World Congress, taking place from May 8 to 11, 2022. This continues Octapharma’s long history of involvement and support of the WFH World Congress and the […]

thaipr.net

26 เม.ย. 65

Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

Terran to advance the development of two of Sanofi’s Phase 3 CNS therapeutics Transaction includes worldwide exclusive rights for development and commercialization in all fields of use Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Sanofi S.A. […]

thaipr.net

22 เม.ย. 65

Translumina launches VIVO ISAR, its Dual-Drug Polymer-free Coated Stent (DDCS) in International markets

Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company’s global growth journey  Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology, announces the launch of VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various International markets including Europe.  As an organization,…

thaipr.net

19 เม.ย. 65

Illumina Singapore Jumps the Ranks to Earn Two Significant Spots in Singapore’s Best Employers Award

The Annual Singapore’s Best Employers survey is sponsored by The Straits Times and marketing firm, Statista. Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) was honoured today to be ranked #17 overall and #1 in Healthcare Equipment & Services in Singapore’s Best Employers Award. The Singapore Employer of Choice is a large scale and comprehensive […]

thaipr.net

18 เม.ย. 65

TauRx’s late-stage clinical trial reaches new milestone

– Significant milestone in the only late-stage clinical trial targeting tau pathology of Alzheimer’s – TauRx on track to announce top line results in May – Trial aims to confirm efficacy of first tau-based treatment for Alzheimer’s TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer’s Disease (AD) research, has announced that the last patient has completed treatment […]

thaipr.net

18 เม.ย. 65
1 … 78 79 80 81 82 … 133

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.